When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XENT - Intersect ENT down 26% premarket on failed study of drug-coated sinus balloon
Intersect ENT Inc.
Intersect ENT (NASDAQ:XENT) slumps 26% premarket on light volume in reaction to unsuccessful results from the randomized ASCEND study evaluating its drug-coated sinus balloon for dilating the frontal sinus ostium to reduce post-balloon dilation edema via the localized delivery of steroid directly to dilated tissue.
More news on: Intersect ENT, Inc., Healthcare stocks news, Stocks on the move,